263 related articles for article (PubMed ID: 3030034)
1. A study of hypothalamic-pituitary-adrenal suppression following curative surgery for Cushing's syndrome due to adrenal adenoma.
Gordon D; Semple CG; Beastall GH; Thomson JA
Acta Endocrinol (Copenh); 1987 Feb; 114(2):166-70. PubMed ID: 3030034
[TBL] [Abstract][Full Text] [Related]
2. Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing's syndrome and others with incidentalomas and subclinical hypercortisolism.
Khawandanah D; ElAsmar N; Arafah BM
Endocrine; 2019 Jan; 63(1):140-148. PubMed ID: 30259310
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing factor (CRF): stimulation in normal controls and in patients with Cushing's syndrome.
Müller OA; Hartwimmer J; Hauer A; Kaliebe T; Schopohl J; Stalla GK; von Werder K
Psychoneuroendocrinology; 1986; 11(1):49-60. PubMed ID: 3010360
[TBL] [Abstract][Full Text] [Related]
4. [Unilateral adrenalectomy for cortisol producing adenoma: prolonged suppression of the hypothalamus-pituitary-adrenal axis].
Arteaga E; González G; López JM; Rodríguez JA; Codner E
Rev Med Chil; 1990 Apr; 118(4):426-9. PubMed ID: 1966792
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing factor in humans. II. CRF stimulation in patients with diseases of the hypothalamo-pituitary-adrenal axis.
Müller OA; Stalla GK; von Werder K
Horm Res; 1987; 25(4):185-98. PubMed ID: 3034758
[TBL] [Abstract][Full Text] [Related]
6. Comparison of one week 0900 h serum cortisol, low and standard dose synacthen tests with a 4 to 6 week insulin hypoglycaemia test after pituitary surgery in assessing HPA axis.
Courtney CH; McAllister AS; McCance DR; Bell PM; Hadden DR; Leslie H; Sheridan B; Atkinson AB
Clin Endocrinol (Oxf); 2000 Oct; 53(4):431-6. PubMed ID: 11012567
[TBL] [Abstract][Full Text] [Related]
7. Corticotropin releasing factor (CRF): diagnostic implications.
Müller OA; Stalla GK; Hartwimmer J; Schopohl J; von Werder K
Acta Neurochir (Wien); 1985; 75(1-4):49-59. PubMed ID: 2986422
[TBL] [Abstract][Full Text] [Related]
8. Time to recovery of the hypothalamic-pituitary-adrenal axis after curative resection of adrenal tumors in patients with Cushing's syndrome.
Doherty GM; Nieman LK; Cutler GB; Chrousos GP; Norton JA
Surgery; 1990 Dec; 108(6):1085-90. PubMed ID: 2247834
[TBL] [Abstract][Full Text] [Related]
9. The use of the corticotropin-releasing hormone test to monitor the recovery of patients with Cushing's disease or Cushing's syndrome due to an adrenal adenoma after adenomectomy.
Hotta MN; Shibasaki T; Suda T; Ling N; Shizume K
Endocrinol Jpn; 1985 Feb; 32(1):113-25. PubMed ID: 2990881
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing's syndrome and non-functional adrenal tumor.
Morio H; Terano T; Yamamoto K; Tomizuka T; Oeda T; Saito Y; Tamura Y; Sasano H
Endocr J; 1996 Aug; 43(4):387-96. PubMed ID: 8930526
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
[TBL] [Abstract][Full Text] [Related]
12. Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary.
Lytras N; Grossman A; Perry L; Tomlin S; Wass JA; Coy DH; Schally AV; Rees LH; Besser GM
Clin Endocrinol (Oxf); 1984 Jan; 20(1):71-84. PubMed ID: 6319053
[TBL] [Abstract][Full Text] [Related]
13. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
[TBL] [Abstract][Full Text] [Related]
14. The insulin hypoglycaemia and overnight metyrapone tests in the assessment of the hypothalamic-pituitary-adrenal axis following pituitary surgery.
Courtney CH; McAllister AS; McCance DR; Hadden DR; Leslie H; Sheridan B; Atkinson AB
Clin Endocrinol (Oxf); 2000 Sep; 53(3):309-12. PubMed ID: 10971447
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of hypothalamo-pituitary-adrenocortical function in children by human corticotropin-releasing hormone (MCI-028) test.
Tanaka T; Hibi I; Shimizu N; Imura H; Tanaka K; Fukata J; Fujieda K; Ichimura T; Kuribayashi T; Ito K
Endocr J; 1993 Oct; 40(5):581-9. PubMed ID: 7951524
[TBL] [Abstract][Full Text] [Related]
16. Human corticotropin-releasing hormone test in patients with hypothalamo-pituitary-adrenocortical disorders.
Fukata J; Shimizu N; Imura H; Hibi I; Tanaka K; Tanaka T; Nakagawa S; Takebe K; Kimura K; Yoshinaga K
Endocr J; 1993 Oct; 40(5):597-606. PubMed ID: 7951526
[TBL] [Abstract][Full Text] [Related]
17. Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease.
Isidori AM; Kaltsas GA; Korbonits M; Pyle M; Gueorguiev M; Meinhardt A; Metz C; Petrovsky N; Popovic V; Bucala R; Grossman AB
J Clin Endocrinol Metab; 2002 Apr; 87(4):1834-40. PubMed ID: 11932327
[TBL] [Abstract][Full Text] [Related]
18. Plasma ACTH-response to the corticotropin releasing factor in patients with Cushing's disease. Comparison with the lysine-vasopressin test.
Catania A; Cantalamessa L; Orsatti A; Mosca G; Minonzio F; Motta P; Reschini E; Zanussi C
Metabolism; 1984 May; 33(5):478-81. PubMed ID: 6325850
[TBL] [Abstract][Full Text] [Related]
19. A case of asymptomatic cortisol producing adrenal adenoma.
Noritake M; Morimoto K; Kosano H; Nemoto Y; Kugai N; Takao M; Murai M; Tamai S; Tanaka K; Nagata N
Endocrinol Jpn; 1992 Feb; 39(1):19-24. PubMed ID: 1606918
[TBL] [Abstract][Full Text] [Related]
20. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
